Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionPrelude Capital Management, Llc
Latest Disclosed Ownership21,813 shares
Latest Disclosed Value $ 1,437,695
Prelude Capital Management, Llc ownership in 1CYTK / Cytokinetics, Incorporated

On May 15, 2026 - Prelude Capital Management, Llc filed a 13F-HR form disclosing ownership of 21,813 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $1,177,902 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 37,539 shares of Cytokinetics, Incorporated. This represents a change in shares of -41.89% during the quarter. The current value of the position is $1,359,386 USD.

Prelude Capital Management, Llc has a history of taking positions in derivatives of the underlying security (1CYTK) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1CYTK / Cytokinetics, Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CYTOKINETICS COM NEW 23282W605 21,813 -15,726 -41.89 1,438 -39.75 0.1099
2026-02-17 2025-12-31 13F CYTOKINETICS COM NEW 23282W605 37,539 -3,938 -9.49 2,385 4.65 0.1755
2025-11-14 2025-09-30 13F CYTOKINETICS COM NEW 23282W605 41,477 5,976 16.83 2,280 94.45 0.1779
2025-08-14 2025-06-30 13F CYTOKINETICS COM NEW 23282W605 35,501 6,947 24.33 1,173 2.18 0.1141
2025-05-15 2025-03-31 13F CYTOKINETICS COM NEW 23282W605 28,554 8,348 41.31 1,148 20.74 0.0873
2025-02-14 2024-12-31 13F CYTOKINETICS COM NEW 23282W605 20,206 1,315 6.96 950 -4.71 0.0596
2024-11-14 2024-09-30 13F/A-1 CYTOKINETICS COM NEW 23282W605 18,891 18,891 997 0.0603
2024-11-14 2024-09-30 13F CYTOKINETICS COM NEW 23282W605 18,891 18,891 997 0.0374
2024-08-14 2024-06-30 13F CYTOKINETICS COM NEW 23282W605 0 -16,023 -100.00 0 -100.00
2024-05-15 2024-03-31 13F CYTOKINETICS COM NEW 23282W605 16,023 4,237 35.95 1,123 14.13 0.0590
2024-02-14 2023-12-31 13F CYTOKINETICS COM NEW 23282W605 11,786 2,086 21.51 984 245.26 0.0652
2023-11-14 2023-09-30 13F CYTOKINETICS COM NEW 23282W605 9,700 631 6.96 286 -3.39 0.0186
2023-08-14 2023-06-30 13F CYTOKINETICS COM NEW 23282W605 9,069 1,767 24.20 296 15.23 0.0193
2023-06-01 2023-03-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 7,302 7,302 257 0.0154
2023-05-15 2023-03-31 13F CYTOKINETICS COM NEW 23282W605 7,302 7,302 257 0.0084
2021-02-16 2020-12-31 13F CYTOKINETICS COM 23282W605 0 -18,564 -100.00 0 -100.00
2020-11-16 2020-09-30 13F CYTOKINETICS COM 23282W605 18,564 7,461 67.20 402 53.44 0.0194
2020-08-14 2020-06-30 13F CYTOKINETICS COM 23282W605 11,103 8,634 349.70 262 803.45 0.0144
2020-05-15 2020-03-31 13F CYTOKINETICS COM 23282W605 2,469 -5,465 -68.88 29 -65.48 0.0019
2020-02-14 2019-12-31 13F CYTOKINETICS COM 23282W605 7,934 7,934 221.34 84 189.66 0.0032
2019-05-15 2019-03-31 13F CYTOKINETICS COM 23282W605 0 -215 -100.00 0 -100.00
2019-02-14 2018-12-31 13F CYTOKINETICS COM 23282W605 215 215 1 0.0001
2018-08-14 2018-06-30 13F CYTOKINETICS COM 23282W605 0 -43,743 -100.00 0 -100.00
2018-05-15 2018-03-31 13F CYTOKINETICS COM 23282W605 43,743 -2,595 -5.60 315 -16.67 0.0229
2018-02-14 2017-12-31 13F CYTOKINETICS COM 23282W605 46,338 10,534 29.42 378 -27.17 0.0304
2017-11-14 2017-09-30 13F CYTOKINETICS COM 23282W605 35,804 11,322 46.25 519 75.34 0.0468
2017-08-14 2017-06-30 13F CYTOKINETICS COM 23282W605 24,482 -387 -1.56 296 -7.50 0.0280
2017-05-15 2017-03-31 13F CYTOKINETICS COM 23282W605 24,869 19,469 360.54 320 384.85 0.0306
2017-02-14 2016-12-31 13F CYTOKINETICS COM 23282W605 5,400 2,500 86.21 66 144.44 0.0080
2016-11-14 2016-09-30 13F CYTOKINETICS COM 23282W605 2,900 1,400 93.33 27 92.86 0.0028
2016-08-15 2016-06-30 13F CYTOKINETICS COM 23282W605 1,500 1,500 -48.28 14 -48.15 0.0020
2016-05-16 2016-03-31 13F CYTOKINETICS COM 23282W605 0 -2,800 -100.00 0 -100.00
2016-02-16 2015-12-31 13F CYTOKINETICS COM 23282W605 2,800 -6,413 -69.61 29 -53.23 0.0045
2015-11-16 2015-09-30 13F CYTOKINETICS COM 23282W605 9,213 5,063 122.00 62 121.43 0.0090
2015-08-14 2015-06-30 13F CYTOKINETICS COM 23282W605 4,150 -2,100 -33.60 28 -33.33 0.0039
2015-05-15 2015-03-31 13F CYTOKINETICS COM 23282W605 6,250 -13,000 -67.53 42 -72.73 0.0058
2015-02-13 2014-12-31 13F CYTOKINETICS COM 23282W605 19,250 0 0.00 154 126.47 0.0226
2014-11-14 2014-09-30 13F CYTOKINETICS COM 23282W605 19,250 6,700 53.39 68 13.33 0.0096
2014-08-14 2014-06-30 13F CYTOKINETICS COM 23282W605 12,550 10,550 527.50 60 215.79 0.0079
2014-05-15 2014-03-31 13F CYTOKINETICS COM 23282W605 2,000 -3,500 -63.64 19 -47.22 0.0025
2014-02-14 2013-12-31 13F CYTOKINETICS COM 23282W605 5,500 5,500 36 0.0059
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-11-14 2024-09-30 13F/A CYTOKINETICS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F CYTOKINETICS COM NEW Call 0 0 n/a n/a n/a
2024-08-14 2024-06-30 13F CYTOKINETICS COM NEW Call 4,100 2.50 222 -20.71 n/a n/a n/a
2024-05-15 2024-03-31 13F CYTOKINETICS COM NEW Call 4,000 280 n/a n/a n/a
2021-02-16 2020-12-31 13F CYTOKINETICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F CYTOKINETICS COM Call 900 19 n/a n/a n/a
2014-08-14 2014-06-30 13F CYTOKINETICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-05-15 2014-03-31 13F CYTOKINETICS COM Call 2,000 19 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.